Pharmaceuticals Evernorth to offer Stelara biosimilar at no copayment Last updated: September 10, 2024 1:59 pm By bexib 0 Min Read Share SHARE This is the second biosimilar the company is offering to customers at this price point. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article Florida and Texas home price growth slows as inventory soars Next Article First barter trade between Russia and China could begin this fall, sources say Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Mastercard and JPMorgan to streamline B2B payments with blockchain Fintech KoinWorks subsidiary faces OJK scrutiny over lender payment delays Fintech Finastra confirms breach amid claims of 400 GB data stolen by hackers Fintech Holiday Sledding: Maximize your reservations and prepare for the Christmas season Hospitality & Tourism
